Literature DB >> 28463513

Characterization of the Polymyxin D Synthetase Biosynthetic Cluster and Product Profile of Paenibacillus polymyxa ATCC 10401.

Charles A Galea, Meiling Han1, Yan Zhu1, Kade Roberts, Jiping Wang1, Philip E Thompson, Jian L1, Tony Velkov.   

Abstract

The increasing prevalence of polymyxin-resistant bacteria has stimulated the search for improved polymyxin lipopeptides. Here we describe the sequence and product profile for polymyxin D nonribosomal peptide synthetase from Paenibacillus polymyxa ATCC 10401. The polymyxin D synthase gene cluster comprised five genes that encoded ABC transporters (pmxC and pmxD) and enzymes responsible for the biosynthesis of polymyxin D (pmxA, pmxB, and pmxE). Unlike polymyxins B and E, polymyxin D contains d-Ser at position 3 as opposed to l-α,γ-diaminobutyric acid and has an l-Thr at position 7 rather than l-Leu. Module 3 of pmxE harbored an auxiliary epimerization domain that catalyzes the conversion of l-Ser to the d-form. Structural modeling suggested that the adenylation domains of module 3 in PmxE and modules 6 and 7 in PmxA could bind amino acids with larger side chains than their preferred substrate. Feeding individual amino acids into the culture media not only affected production of polymyxins D1 and D2 but also led to the incorporation of different amino acids at positions 3, 6, and 7 of polymyxin D. Interestingly, the unnatural polymyxin analogues did not show antibiotic activity against a panel of Gram-negative clinical isolates, while the natural polymyxins D1 and D2 exhibited excellent in vitro antibacterial activity and were efficacious against Klebsiella pneumoniae and Acinetobacter baumannii in a mouse blood infection model. The results demonstrate the excellent antibacterial activity of these unusual d-Ser3 polymxyins and underscore the possibility of incorporating alternate amino acids at positions 3, 6, and 7 of polymyxin D via manipulation of the polymyxin nonribosomal biosynthetic machinery.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28463513     DOI: 10.1021/acs.jnatprod.6b00807

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

Review 1.  Causes of polymyxin treatment failure and new derivatives to fill the gap.

Authors:  Selena Chiu; Anna M Hancock; Bob W Schofner; Katherine J Sniezek; Nashaly Soto-Echevarria; Gabrielle Leon; Darshan M Sivaloganathan; Xuanqing Wan; Mark P Brynildsen
Journal:  J Antibiot (Tokyo)       Date:  2022-09-20       Impact factor: 3.424

2.  Pan-genome analysis of Paenibacillus polymyxa strains reveals the mechanism of plant growth promotion and biocontrol.

Authors:  Liangliang Zhou; Ting Zhang; Shan Tang; Xueqin Fu; Shuijing Yu
Journal:  Antonie Van Leeuwenhoek       Date:  2020-08-20       Impact factor: 2.271

3.  Complete Genome Sequence of Industrial Biocontrol Strain Paenibacillus polymyxa HY96-2 and Further Analysis of Its Biocontrol Mechanism.

Authors:  Yuanchan Luo; Yuejuan Cheng; Jincui Yi; Zhijun Zhang; Qian Luo; Daojing Zhang; Yuanguang Li
Journal:  Front Microbiol       Date:  2018-07-12       Impact factor: 5.640

4.  A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens.

Authors:  Kade D Roberts; Yan Zhu; Mohammad A K Azad; Mei-Ling Han; Jiping Wang; Lynn Wang; Heidi H Yu; Andrew S Horne; Jo-Anne Pinson; David Rudd; Nicolas H Voelcker; Nitin A Patil; Jinxin Zhao; Xukai Jiang; Jing Lu; Ke Chen; Olga Lomovskaya; Scott J Hecker; Philip E Thompson; Roger L Nation; Michael N Dudley; David C Griffith; Tony Velkov; Jian Li
Journal:  Nat Commun       Date:  2022-03-25       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.